Colorectal Cancer Trial, Recruiting NCT05676190 Sponsor: ShiCang Yu Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT05676190
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 70 years old
  • People who have been diagnosed with colorectal cancer at stage III or stage IV
  • People who have at least one tumour or lesion outside the brain that can be measured using standard imaging criteria
  • People whose cancer has stopped responding to one or two previous standard treatments, who have relapsed, or who could not tolerate or chose not to continue one or two previous standard treatments
  • People whose doctors expect them to live for at least 90 days
  • People whose major organs (such as heart, liver, and kidneys) are functioning normally
  • People who are willing to participate, have signed a consent form, and are able to attend follow-up appointments

Who may not be able to join:

  • People who have taken part in another drug clinical trial within the 4 weeks before joining this study
  • People with high blood pressure that is not well controlled by a single blood pressure medication, or who have heart conditions such as reduced blood flow to the heart, a history of heart attack, irregular heart rhythm, or heart function problems
  • People with a history of substance abuse who are unable to stop, or people with a history of mental health disorders
  • People with an active infection (fungal, bacterial, viral, or other) that cannot be controlled or that requires antibiotic treatment
  • People who, after previous chemotherapy, still have moderate or serious ongoing side effects at the time of joining (confirm with trial site for exact grading details)
  • People with a known history of HIV, or who test positive for hepatitis B or hepatitis C
  • People who have an indwelling tube or drain in place, such as a bile duct drain or a fluid drain around the lungs, heart, or abdomen — though certain central venous lines and some other tubes may be considered acceptable by the trial doctors (confirm with trial site)
  • People who have cancer that has spread to the brain, or who have a history of brain or nervous system conditions such as seizures, stroke, bleeding in the brain, dementia, or autoimmune diseases affecting the brain or nervous system

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
ShiCang Yu
Registry
ClinicalTrials.gov
Start date
9 January 2023
Est. completion
30 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Disease control rate (DCR); objective response rate (ORR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov